Alphonse Galdes - Net Worth and Insider Trading

Alphonse Galdes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alphonse Galdes owns 1 companies in total, including Biogen Inc (BIIB) .

Click here to see the complete history of Alphonse Galdes’s form 4 insider trades.

Insider Ownership Summary of Alphonse Galdes

Ticker Comapny Transaction Date Type of Owner
BIIB Biogen Inc 2019-09-19 EVP Pharmaceutical Oper & Tech

Alphonse Galdes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alphonse Galdes Ownership Network

Ownership Network List of Alphonse Galdes

No Data

Ownership Network Relation of Alphonse Galdes

Alphonse Galdes Owned Company Details

What does Biogen Inc do?

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Who are the key executives at Biogen Inc?

Alphonse Galdes is the EVP Pharmaceutical Oper & Tech of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Alphonse Galdes made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , a net sale of 5,532 shares made by Susan H Alexander , and a net sale of 568 shares made by Priya Singhal .

In summary, during the past 3 months, insiders sold 568 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 568 shares. During the past 18 months, 11,710 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,710 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.


Biogen Inc Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Alphonse Galdes Mailing Address

Above is the net worth, insider trading, and ownership report for Alphonse Galdes. You might contact Alphonse Galdes via mailing address: Biogen Inc., 225 Binney St., Cambridge Ma 02142.